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Blood glucose levels are tightly controlled, a process
thought to be orchestrated primarily by peripheral
mechanisms (insulin secretion by b cells, and insulin
action on muscle, fat, and liver). The brain also plays
an important, albeit less well-defined role. Subsets of
neurons in the brain are excited by glucose; in many
cases this involves ATP-mediated closure of KATP
channels. To understand the relevance of this, we
are manipulating glucose sensing within glucose-
excited neurons. In the present study, we demon-
strate that glucose excitation of MCH-expressing
neurons in the lateral hypothalamus is mediated by
KATP channels and is negatively regulated by UCP2
(a mitochondrial protein that reduces ATP produc-
tion), and that glucose sensing by MCH neurons
plays an important role in regulating glucose homeo-
stasis. Combined, the glucose-excited neurons are
likely to play key, previously unexpected roles in
regulating blood glucose.
INTRODUCTION
Numerous studies have demonstrated that the brain can affect
blood glucose levels (Rother et al., 2008; Sandoval et al., 2009;
Schwartz and Porte, 2005), raising the possibility that the CNS
contributes to maintenance of the euglycemic state (and, by
inference, to the pathogenesis of type 2 diabetes). With this in
mind, it is of interest that subsets of neurons in the brain
are capable of sensing glucose (Levin et al., 2004). By acting
in conjunction with downstream autonomic efferents, these
glucose-sensing neurons could provide a basis for central regu-
lation of blood glucose levels. While there has been much spec-
ulation about the existence and importance of such neural
mechanisms, complexities of the brain, combined with difficul-
ties in probing its function, have left this issue unresolved.
One approach is to genetically perturb glucose sensing in
select subsets of neurons, and then assess effects on bloodCell Mglucose levels. Glucose inhibits certain neurons (for example,
AgRP neurons in the arcuate nucleus and orexin neurons in
the lateral hypothalamus) and stimulates others (for example,
POMC neurons in the arcuate nucleus, MCH neurons in the
lateral hypothalamus, and chemically undefined neurons in
the ventromedial hypothalamus and in the hindbrain) (Balfour
et al., 2006; Burdakov et al., 2005; Claret et al., 2007; Ibrahim
et al., 2003; Levin et al., 2004; Mountjoy et al., 2007; Parton et al.,
2007; Routh, 2002). The mechanism responsible for glucose
inhibition of neurons is incompletely understood (Burdakov and
Lesage, 2009). In contrast, a well-defined mechanism accounts
for most cases of glucose excitation of neurons (Ashford et al.,
1990; Ibrahim et al., 2003; Kang et al., 2004; Miki et al., 2001;
Parton et al., 2007). This pathway is similar to that which occurs
in glucose-excited pancreatic b cells (i.e., [ glucose/ [ ATP
production/ ATP-mediated closure of KATP channels/ depo-
larization). Using an approach originally developed for pancre-
atic b cells (Koster et al., 2000; Remedi et al., 2009), we are per-
turbing glucose sensing by genetically expressing mutant Kir6.2
subunits in specific groups of glucose-excited neurons. The
mutation (Kir6.2[K185Q,DN30]) being employed renders KATP
channels resistant to closure by ATP, hence abrogating excita-
tion by glucose (Koster et al., 2000; Parton et al., 2007; Remedi
et al., 2009).
We previously used a related approach to disturb glucose
sensing in POMC neurons (Parton et al., 2007). Of interest, this
led to impairment in peripheral glucose homeostasis. It is impor-
tant to note, however, that POMC neurons represent only a small
percentage of all glucose-excited neurons. Left unresolved is the
role of these other glucose-excited neurons. This question is
significant because if these other glucose-excited neurons are
also playing an important role, then their combined effects on
glucose homeostasis are expected to be large.
The present study focuses on MCH neurons, which are of
interest because their anatomy is distinctly different from that
of POMC neurons (Bittencourt et al., 1992). MCH neurons are
found exclusively in the lateral hypothalamus and zona incerta
while POMC neurons are found in the arcuate nucleus and the
nucleus of the solitary tract. Two approaches have been used
to perturb glucose sensing in MCH neurons. To decrease
glucose sensing, we expressed a mutant Kir6.2 subunit (Kir6.2
[K185Q,DN30]) in MCH neurons, rendering KATP channelsetabolism 12, 545–552, November 3, 2010 ª2010 Elsevier Inc. 545
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Figure 1. MCHNeuronsAreGlucoseExcited
andExpressSur1-ContainingKATPChannels
(A) Structure of Mch-Cre BAC transgene.
(B) Double immunohistochemistry for tdTomato
(red) and MCH peptide (green) in the lateral hypo-
thalamus of Mch-Cre/lox-tdTomato mice.
(C and D) Representative traces recorded in the
whole-cell patch clamp mode from GFP-positive
neurons of Mch-Cre/Z/EG mice. (C) Spontane-
ously firing MCH neuron that responded to
glucose. (D) Silent MCH neuron that responded
to glucose with depolarizing current injection
(20pA for 3 s with 20 s interval).
(E) Effects of glucose (5 mM/ 1 mM/ 5 mM) on
membrane potential of ‘‘tolbutamide-responding’’
GFP-positive neurons of Mch-Cre/Z/EG mice.
The averaged membrane potential of the last
3 min of the indicated condition from each record-
ing was used for calculation (n = 9, mean ± SEM).
Cell Metabolism
Glucose Sensing by MCH Neuronsresistant to closure by ATP. To increase glucose sensing, we
deleted UCP2 selectively from MCH neurons. UCP2 is a mito-
chondrial protein that reduces ATP production (Krauss et al.,
2005). In its absence, MCH neurons are expected to have
increased glucose-stimulated ATP levels, thus augmenting
glucose-stimulated closure of KATP channels (just as UCP2 defi-
ciency does in pancreatic b cells [Krauss et al., 2003; Zhang
et al., 2001, 2006] and in POMC neurons [Parton et al., 2007]).
RESULTS
Generation and Characterization of Mch-Cre
Transgenic Mice
A BAC genomic clone containing the mouseMch gene was used
to drive expression of Cre recombinase (Cre) (Figure 1A). Eight
lines of Mch-Cre mice were generated and then crossed with
lox-GFP reporter mice (Z/EG) (Novak et al., 2000) (referred to
as Mch-Cre/Z/EG mice). Two lines were found to express GFP
in the lateral hypothalamus and zona incerta (known sites of
MCH expression) (Bittencourt et al., 1992; Elias et al., 1998),
but not in other sites in the brain. To characterize Cre expression
in greater detail, one of the two lines was then crossed with
the more sensitive lox-tdTomato reporter mouse, Gt(ROSA)
26Sortm14(CAG-tdTomato)Hze (Madisen et al., 2010). Mch-Cre/lox-
tdTomato mice expressed tdTomato in neurons in the lateral
hypothalamus (LH) and in the zona incerta (ZI), and as expected,
not in other sites in the brain. Double immunohistochemical546 Cell Metabolism 12, 545–552, November 3, 2010 ª2010 Elseviern
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protein (Figure 1B) revealed that all tdTo-
mato-positive cell bodies expressed
MCH, and that the majority (80%) of
MCH peptide-positive cell bodies ex-
pressed tdTomato.
MCH Neurons Are Excited
by Glucose and Express KATP
Channels
Whole-cell electrophysiological record-
ings were performed on GFP-positive
eurons (i.e., MCH neurons) of Mch-Cre/Z/EG mice, and
embrane potentials and firing rates were assessed (Figures
C–1E). Consistent with previous findings (Burdakov et al.,
005; van den Pol et al., 2004), we observed that 30%
1/39) of MCH neurons were spontaneously firing while
70% (28/39) were electrically silent, requiring injection of
epolarizing current for induction of action potentials. Regard-
ss of their firing properties, 70% of all MCH neurons were
xcited by glucose. Specifically, 8/11 of the spontaneously
ring neurons (example shown in Figure 1C) and 20/28 of the
ilent neurons (example shown in Figure 1D) were reversibly
yperpolarized when extracellular glucose was lowered from
to 1 mM. Of note, these glucose concentrations are consis-
nt with those reported, in vivo, in the lateral hypothalamus
ilver and Erecinska, 1998). In addition, in response to 1 mM
lucose, the spontaneously firing MCH neurons showed
reduction in firing rates (Figure 1C), and likewise, the ‘‘silent’’
CH neurons showed a decrease in firing rates induced by
jection of current (Figure 1D). These findings demonstrate
at the majority (70%) of MCH neurons are excited by
lucose, which is in agreement with an earlier study (Burdakov
t al., 2005).
Glucose-excited POMC neurons and pancreatic b cells
xpress Sur1-containing KATP channels (Ibrahim et al., 2003;
agaki et al., 1995; Parton et al., 2007; Sakura et al., 1995).
o determine if MCH neurons are similar in this regard, a
ur1 subunit-specific KATP channel blocker, tolbutamide, was
B0.0
0.2
0.4
0.6
0.8
1.0
0.001 0.01 0.1 1 10
ATP (mM)
R
el
at
iv
e 
cu
rre
nt
 (I/
I
m
a
x
)
0.0
WT
Mch-Cre/mutKir6.2
Tolbutamide
5 mM 1 mM glucose
Tolbutamide
i) WT ii) Mch-Cre/mutKir6.2
5 mM 1 mM glucose
C
D
0.1 1 10
-80
-70
-60
-50
12 10
24
12
47
6 10
18 5 27
20
 m
V -52 -67 mV
A
0.5 1.0 0
ATP (mM)
Cu
rre
nt
 (p
A) 0
-80
0 0.01 0.05 0.1
0
-80
5 10 0
ATP (mM)
0 0.01 0.1 1
i) WT
ii) Mch-Cre/mutKir6.2
Cu
rre
nt
 (p
A)
10 sec
mV
20
 m
V 
Glucose (mM)
M
em
br
an
e 
Po
te
nt
ia
l (m
V)
WT
Mch-Cre/mutKir6.2
Mch-Cre/mutKir6.2
WT
0 20 40 60 80 100 120
*
*
GTTE
Bl
oo
d 
gl
uc
os
e 
(m
g/d
l)
0
100
200
300
50
150
250
Time after glucose injection (min)
20pA
20pA
Figure 2. Expression of Mutant Kir6.2 in
MCH Neurons Blocks Glucose Sensing
(A and B) Effects of ATP on KATP channel current.
Recordings were performed on inside-out patches
derived from GFP-positive (i.e., MCH) neurons. (A)
Representative macroscopic current traces re-
corded at 60 mV from patches derived from (i)
WT (Mch-Cre/Z/EG) and (ii) Mch-Cre/mutKir6.2/
Z/EG mice. Concentrations of ATP are indicated
above the corresponding traces. (B) Summarized
effects of ATP on KATP channel current. Data
were normalized to the maximal current recorded
in the absence of ATP (mean ± SEM, n = 5–7).
(C) Effects of glucose onMCHneuronswithin brain
slices. Representative traces recorded in the
whole-cell patch clamp mode from GFP-positive
neurons derived from (i) WT (Mch-Cre/Z/EG) and
(ii)Mch-Cre/mutKir6.2/Z/EG mice.
(D) Effects of glucose on membrane potential
(mean ± SEM, values above each point represent
the number of neurons assessed).
(E) Effects of mutant Kir6.2 on glucose tolerance in
intact mice. Representative glucose tolerance
curves of 8-week-old male mice (mean ± SEM,
n = 7–10 per genotype, 2 g/Kg glucose i.p.). *p <
0.05 (unpaired t tests), compared with wild-type
littermates at a given time point.
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Glucose Sensing by MCH Neuronsadded at the end of the recordings (see Figures S1A and S1B
available online). In total, 70% of all MCH neurons were
excited by tolbutamide. For the glucose-excited subset of
MCH neurons (which represents 70% of all MCH neurons
as noted above), nearly all were excited by tolbutamide (17 of
19 neurons). For the subset that was not excited by glucose
(which represents 30% of all MCH neurons, of which five
were tested for effects of tolbutamide), none were excited by
tolbutamide. In a separate set of studies, summarized in Fig-
ure 1E, we examined membrane potential as glucose was
changed from 5 mM / 1 mM / 5 mM, and then again as
tolbutamide was added. As expected, the ‘‘tolbutamide-
responding’’ MCH neurons were reversibly hyperpolarized by
1 mM glucose. In contrast, the ‘‘tolbutamide-resistant’’ MCH
neurons (Figure S1C), and also randomly selected thalamic
neurons (Figure S1D), were unaffected by 1 mM glucose.
Finally, an immunohistochemical approach was used to assess
Sur1 expression (Figure S1E). Consistent with the observed
electrophysiologic responses to tolbutamide, 75% (335 out
of 435) of all MCH-positive neurons were immunopositive
for Sur1. Thus, as assessed using tolbutamide, nearly all
glucose-sensing MCH neurons have Sur1-containing KATP
channels, and this trait distinguishes the ‘‘glucose-sensing’’
from the ‘‘non-glucose-sensing’’ MCH neurons.Cell Metabolism 12, 545–552, NExpression ofMutant Kir6.2 inMCH
Neurons
To impair glucose sensing in MCH
neurons, we utilized Rosa26 knockin
mice in which, following Cre-mediated
deletion of a STOP cassette, CMV/Actin
promoter elements drive expression of
Kir6.2[K185Q,DN30] (Remedi et al.,2009). This renders KATP channels resistant to closure by ATP,
abrogating excitation by glucose (Koster et al., 2000; Remedi
et al., 2009). To confirm that ATP sensitivity of KATP channels
was indeed altered in MCH neurons of Mch-Cre/mutKir6.2
mice, we performed recordings on inside-out excised patches
derived from MCH neurons of Mch-Cre/Z/EG (control) and
Mch-Cre/mutKir6.2/Z/EG mice (expressing mutant Kir6.2).
Currents were measured as ATP was applied, in increasing
concentrations, to the cytosolic surface of the patches. As can
be seen in Figures 2A and 2B, KATP channels from control
MCH neurons closed as ATP concentrations were increased
with a Ki ([ATP] that causes half-maximal inhibition) of 30 mM.
As expected, expression of mutant Kir6.2 in MCH neurons
greatly reduced sensitivity to closure by ATP (by 200 fold),
with the Ki for ATP increasing to 5.8 mM.
Using brain slice preparations, we next determined if expres-
sion of ATP-insensitive KATP channels disrupted glucose sensing
in MCH neurons. First, we observed that only 14% of MCH
neurons (3/22) from Mch-Cre/mutKir6.2 mice (compare with
30% of MCH neurons from control mice) had spontaneous
action potentials at 5 mM glucose. Membrane resistance
of MCH neurons was calculated from the change in mem-
brane potential in response to a hyperpolarizing current pulse
(40 pA, 1 s in duration). At 5 mM glucose, membrane resistanceovember 3, 2010 ª2010 Elsevier Inc. 547
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Glucose Sensing by MCH Neuronsof MCH neurons in Mch-Cre/mutKir6.2 mice was significantly
reduced (WT, 1081 ± 65 MU, n = 7; mutKir6.2, 540 ± 47 MU,
n = 7; mean ± SEM), consistent with KATP channels being more
open. Second, nearly all MCH neurons fromMch-Cre/mutKir6.2
mice (18/20) were no longer hyperpolarized as extracellular
glucose was lowered from 5 to 1 mM (example shown in Fig-
ure 2C). This is in striking contrast to MCH neurons from control
mice, as noted above, in which 70% were hyperpolarized by
a similar fall in glucose. AlthoughMCHneuronswith ATP-insensi-
tive KATP channels are no longer excited by glucose, they are still
responsive to tolbutamide, as application of the KATP channel
blocker resulted in robust membrane depolarization and stimula-
tionof actionpotentials (Figure2C) in14of 16 tolbutamide-treated
neurons. Third, as shown in Figure 2D, glucose-induced depolar-
ization of MCH neurons, while readily observed in MCH neurons
from control mice, was completely abrogated in MCH neurons
from Mch-Cre/mutKir6.2 mice. Thus, expression of mutant KATP
channels in MCH neurons disrupts glucose sensing.
To assess the effects of mutant KATP channels on signaling
processes thought to be independent of KATP channels, we eval-
uated the effects of orexin and glutamate on MCH neurons. As
previously reported (van den Pol et al., 2004), orexin depolarized
MCH neurons from control mice, and this effect was unaltered in
MCH neurons from Mch-Cre/mutKir6.2 mice (Figure S2). Like-
wise, glutamate similarly excitedMCH neurons from both control
and Mch-Cre/mutKir6.2 mice (data not shown). Taken together,
the above findings provide direct evidence that MCH neurons
sense glucose via a KATP channel-dependant pathway.
Glucose Sensing by MCH Neurons Regulates Peripheral
Glucose Homeostasis
We next investigated the effect of defective glucose sensing
in MCH neurons on whole-body glucose homeostasis. By
comparing Mch-Cre/mutKir6.2 mice (mutKir6.2) with their
wild-type littermates (WT) (8-week-old males), we observed no
difference in body weight (WT, 26.94 ± 0.47 g, n = 15; mutKir6.2,
26.46 ± 0.61 g, n = 16; mean ± SEM), daily food intake (WT,
6.17 ± 0.29 g chow/day, n = 12; mutKir6.2 mice, 6.95 ± 1.23 g
chow/day, n = 8; mean ± SEM), ad libitum-fed blood glucose
levels (WT, 193.3 ± 9.1 mg/dl, n = 11; mutKir6.2, 196.1 ±
8.1 mg/ml, n = 11; mean ± SEM), or overnight fasted blood
glucose levels (WT, 110.0 ± 7.6 mg/dl, n = 7; mutKir6.2 mice,
113.9 ± 7.7 mg/dl, n = 8; mean ± SEM). To examine the dynamic
response of Mch-Cre/mutKir6.2 mice to an acute increase in
blood glucose concentration, glucose tolerance tests were
performed on 8-week-old wild-type and Mch-Cre/mutKir6.2
mice (Figure 2E). Following the exogenous glucose load, Mch-
Cre/mutKir6.2 mice displayed increased excursions in blood
glucose (i.e., impaired glucose tolerance). These effects were
not due to unexpected expression of mutant Kir6.2 in pancreatic
b cells (see Figure S3 for details), and were not due to nonspe-
cific effects of the Mch-Cre transgene, as no effect was seen
in Mch-Cre mice lacking the mutKir6.2 allele (data not shown).
Thus, glucose sensing by MCH neurons plays an important
role in maintaining peripheral glucose homeostasis.
MCH Neurons Express UCP2
In pancreatic b cells and POMC neurons, glucose sensing is
negatively regulated by UCP2 (Parton et al., 2007; Zhang et al.,548 Cell Metabolism 12, 545–552, November 3, 2010 ª2010 Elsevier2001). AsUcp2mRNA is abundantly expressed in the LH (Parton
et al., 2007; Richard et al., 1999), we hypothesized that UCP2
might negatively regulate glucose sensing in MCH neurons as
well. Double in situ hybridization/immunohistochemistry anal-
yses for Ucp2 mRNA and MCH peptide demonstrate that
95% of MCH neurons in LH and ZI express abundant Ucp2
mRNA (Figure 3A). Thus, like pancreatic b cells (Zhang et al.,
2001) and POMC neurons (Parton et al., 2007), glucose-excited
MCH neurons coexpress Sur1-containing KATP channels (Fig-
ure S1E) and Ucp2 (Figure 3A).
Glucose Sensing in MCH Neurons Is Regulated by UCP2
Mice were generated with lox sites flanking exons 2 (start codon)
and 3 of the Ucp2 gene (see Figures S4A–S4D for details and
validation of the Ucp2lox allele). Ucp2lox/lox mice were then
crossed with Mch-Cre mice to generate Mch-Cre/Ucp2lox/lox
animals. The Z/EG GFP reporter transgene was also present
for visualization of MCH neurons. Electrophysiologic studies
revealed that, in the case of MCH neurons lacking UCP2,
44% of MCH neurons (7/16) fired spontaneously at 5 mM
glucose. This is an increase over the 30% of control neurons
(11/39) that fired spontaneously (as previously noted). When
membrane potential was examined in response to different
concentrations of glucose (Figure 3B), we found that MCH
neurons from Mch-Cre/Ucp2lox/lox mice exhibited a parallel but
significantly left-shifted dose-response curve to glucose, indi-
cating that disruption of UCP2 in MCH neurons enhances
glucose-induced depolarization.
We next assessed the physiologic consequences of deleting
UCP2 from MCH neurons. Although Mch-Cre/Ucp2lox/lox mice
showed no difference from control littermates (8-week-old
males) in either body weight (Ucp2lox/lox, 28.10 ± 0.69 g, n = 12;
Mch-Cre/Ucp2lox/lox, 28.79 ± 1.04 g, n = 8; mean ± SEM) or food
intake (Ucp2lox/lox, 4.40 ± 0.11 g chow/day, n = 10; Mch-Cre/
Ucp2lox/lox, 4.61 ± 0.15 g chow/day, n = 7; mean ± SEM), ad libi-
tum-fed and overnight fasted blood glucose levels were signifi-
cantly reduced (Figure 3C). In glucose tolerance tests, Mch-
Cre/Ucp2lox/lox mice had a markedly reduced rise in blood
glucose levels (Figure 3D). This effect is not due to deletion of
UCP2 from pancreatic b cells, because Mch-Cre mice do not
express Cre activity in pancreatic islets (as noted earlier), and
in agreement with this, Ucp2 mRNA levels were unaltered
in islets of Mch-Cre/Ucp2lox/lox mice (Figure S4E). Finally, we
assessed insulin levels during the glucose tolerance test (Fig-
ure 3E) and found that they were not increased (but instead
tended to be decreased) in Mch-Cre/Ucp2lox/lox mice. This indi-
cates that alterations in insulin secretion by b cells, mediated by
either direct (i.e., via unexpected consequences in the b cell) or
indirect pathways (i.e., via the brain), are not driving the fall in
glucose levels—instead b cells are responding secondarily to
the lower glucose levels. This suggests that MCH neurons affect
blood glucose levels by controlling glucose production by the
liver, and/or by increasing glucose uptake intomuscle and/or fat.
Mutant KATP Channels Block the Effects of UCP2
Deficiency
We hypothesize that UCP2 deficiency increases glucose-medi-
ated excitation of MCH neurons (with the subsequent effects
on peripheral glucose homeostasis) by increasing ATP withinInc.
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Figure 3. Deleting UCP2 in MCH Neurons Augments
Glucose Sensing
(A) Double immunohistochemistry/in situ hybridization
for MCH peptide (DAB, brown stain) and Ucp2 mRNA
(35S-labeled cRNA probe, silver grains) in wild-type mice.
(B) Effects of UCP2 deletion on glucose sensing by MCH
neurons. Dose-response curve of glucose-stimulated depo-
larization of GFP-positive neurons from WT (Mch-Cre/Z/EG)
and Mch-Cre/Ucp2lox/lox/Z/EG mice (mean ± SEM values
above each point represent the number of neurons assessed,
two-way ANOVA test, pinteraction = 0.95, pcolume = 0.02,
prow = 0.001).
(C) Blood glucose levels of ad libitum-fed and overnight fasted,
8-week-old male mice (mean ± SEM, n = 8–10 per genotype).
*p < 0.05; **p < 0.01, compared with wild-type littermates
(unpaired t tests).
(D) Representative glucose tolerance curves of 8-week-old
male mice (mean ± SEM, n = 8–10 per genotype, 2 g/Kg
glucose i.p.). *p < 0.05; **p < 0.01, compared with wild-type
at a given time point (unpaired t tests).
(E) Insulin levels during glucose tolerance test (mean ± SEM,
n = 8–10 per genotype, 2 g/Kg glucose i.p.).
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Glucose Sensing by MCH NeuronsMCH neurons, which then closes KATP channels. However, it is
also possible that UCP2 deficiency could produce effects via
other signaling pathways. If ATP-mediated closure of KATP chan-
nels is involved (as we hypothesize), then expression of mutant
Kir6.2 (which renders KATP channels resistant to closure by
ATP) should completely suppress the UCP2-deficient pheno-
type. To evaluate this, we generated Mch-Cre/Ucp2lox/lox/
mutKir6.2 mice. This was accomplished by crossing Mch-Cre/
Ucp2lox/lox mice with Ucp2lox/lox/mutKir6.2 mice to produce the
four groups of littermate study subjects shown in Figure 4. As
observed before, Mch-Cre/Ucp2lox/lox mice (lacking UCP2 in
MCH neurons) had reduced blood glucose levels in the fed state
(Figure 4A) and a reduced rise in blood glucose during the
glucose tolerance test (Figures 4B and 4C). Of note, in Mch-
Cre/Ucp2lox/lox/mutKir6.2 mice, expression of mutant Kir6.2
completely prevented the glucose-lowering effects of UCP2
deficiency. In fact, blood glucose levels during the glucose toler-
ance test were increased above that seen in control mice, which
is what we observed in Mch-Cre/mutKir6.2 mice (Figure 2E).
In the presence of mutant Kir6.2, UCP2 deficiency was without
effect. These results are consistent with the view that ATP-medi-Cell Metabolism 12,ated regulation of KATP channels in MCH neurons is
downstream, and hence themechanism for, UCP2-
mediated effects on glucose homeostasis.
DISCUSSION
Diverse subsets of neurons in the brain, including
POMC neurons in the arcuate nucleus, MCH
neurons in the lateral hypothalamus, and chemi-
cally undefined neurons in the VMH and hindbrain,
are excited by glucose (Balfour et al., 2006; Burda-
kov et al., 2005; Ibrahim et al., 2003; Levin et al.,
2004; Parton et al., 2007; Ritter et al., 1981; Song
and Routh, 2005). This is of interest because it
provides a means by which the brain can sense
and subsequently respond to increased bloodglucose levels. In support of an important role for this process,
we have previously disrupted glucose sensing in POMC neurons
and found that this impaired peripheral glucose homeostasis
(Parton et al., 2007). Left unresolved, however, is whether
POMC neurons uniquely perform this function, or, if other
glucose-excited neurons, one example being MCH neurons,
along with POMC neurons comprise a network of glucose-
sensing, peripheral blood glucose-regulating neurons.
In the present study, we genetically altered glucose excita-
tion of MCH neurons—we decreased it by expressing ATP-
resistant KATP channels and increased it by deleting UCP2
(which is expected to increase glucose-stimulated ATP produc-
tion). These studies show (1) that glucose sensing in MCH
neurons operates via ATP-mediated closure of Sur1-containing
KATP channels, (2) that this process is negatively regulated by
UCP2 (likely via an ATP-KATP channel-based mechanism),
and (3) that glucose sensing in MCH neurons (either decreased
or increased) impacts meaningfully on peripheral glucose
homeostasis. Thus, MCH neurons, like POMC neurons, regu-
late glucose homeostasis. Combined, glucose-excited neu-
rons (MCH neurons, POMC neurons, and possibly other545–552, November 3, 2010 ª2010 Elsevier Inc. 549
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Figure 4. Mutant KATP Channels Block the Effects of UCP2 Defi-
ciency in MCH Neurons
(A) Blood glucose levels of ad libitum-fed 8-week-old male mice (mean ± SEM,
n = 7–8 per genotype). *p < 0.05; **p < 0.01, compared with littermates (one-
way ANOVA assay).
(B) Representative glucose tolerance curves of 8-week-old male mice (mean ±
SEM, n = 7–8 per genotype, 2 g/kg glucose i.p.).
(C) GTT data from (B) expressed as area under the curve. *p < 0.05; **p < 0.01;
***p < 0.001, compared with littermates (one-way ANOVA assay).
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taining the euglycemic state.EXPERIMENTAL PROCEDURES
Animal Care
Care of all animals and procedures was approved by the Beth Israel
Deaconess Medical Center Institutional Animal Care and Use Committee.
Mice were housed at 22C–24C using a 12 hr light/12 hr dark cycle with550 Cell Metabolism 12, 545–552, November 3, 2010 ª2010 Elsevierstandard mouse chow (Teklad F6 Rodent Diet 8664, 4.05 kcal/g, 3.3 kcal/g
metabolizable energy, 12.5% kcal from fat, Harlan Teklad, Madison, WI) and
water provided ad libitum.
Generation of Mch-Cre BAC Transgenic Mice
Amouse BAC genomic clone containing theMch gene along with64 kb of 50
and 34 kb of 30 flanking sequence was used to generate MCH-Cre mice as
previously reported (Dhillon et al., 2006). Please see the Supplemental Exper-
imental Procedures for greater details.
Generation of Mch-Cre/mutKir6.2 Mice
Mch-Cre mice were mated with Rosa26-Kir6.2[K185Q,DN30] mice (Remedi
et al., 2009), and only littermates were used as study subjects. Please see
the Supplemental Experimental Procedures for genotyping information.
Generation of Mch-Cre/Ucp2lox/lox Mice
Mch-Cre transgenicmicewerematedwithUcp2lox/+mice (129, C57Bl/6mixed
background), and a breeding colony was maintained by mating Mch-Cre/
Ucp2lox/loxmice withUcp2lox/loxmice. Littermates were used as study subjects
to avoid any potential confounding effects due to differences in genetic back-
grounds. Please see the Supplemental Experimental Procedures for greater
details in the generation of lox-Ucp2 allele and genotyping information.
Double Immunohistochemistry/In Situ Hybridization for MCH
Peptide/Ucp2
Ucp2 in situ hybridization was performed as described previously (Parton
et al., 2007). For double Ucp2 in situ hybridization and MCH immunohisto-
chemistry, sections processed for in situ hybridization were incubated with
chicken anti-MCH primary antiserum (Santa Cruz), followed by a 2 hr incuba-
tion in biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch Labora-
tories; 1:1000). Sections were incubated with avidin-biotin complex (Vectas-
tain Elite ABC Kit, Vector Laboratories; 1:500) and then incubated in 0.04%
diaminobenzidine tetrahydrochloride (DAB; Sigma) and 0.01% hydrogen
peroxide in PBS. The DAB reaction was quenched by two washes with PBS.
Glucose Homeostasis Studies
Ad libitum-fed-state blood glucose levels were measured between 9 a.m. and
10 a.m. Fasted blood glucose levels were measured after an overnight fast
(food removed at 5 p.m., blood sampled between 9 a.m. and 10 a.m. the
next day). For glucose tolerance studies, animals fasted overnight (16 hr)
were administered i.p. with 2 g/kg of glucose. Blood was sampled from the
tail vein, and glucose levels were measured with a glucometer (Roche Diag-
nostics) at 15, 30, 60, and 120 min. For assessment of insulin levels during
the GTT, blood samples were collected at above time points and serum insulin
levels were assayed using a commercially available kit (Rat Insulin ELISA kit,
Crystal Chem Inc. Chicago, IL).
Electrophysiology
Primary Hypothalamic Cultures and Inside-Out Excised
Patch Recordings
Lateral hypothalamic nuclei were microdissected, minced, and mechanically
dissociated using the Papain Dissociation System (Worthington, Lakewood,
NJ). Cells were isolated and seeded onto Thermanox glass coverslips (Nalge
Nunc International, Rochester, NY) in Neurobasal A medium (Invitrogen) sup-
plemented with 13 B27 (Invitrogen), 0.4 mM L-glutamine, and 1% fetal calf
serum. For the initial plating, 25 uM glutamic acid was added. The media
was changed every 3–5 days, and excised patch recordings were made on
GFP-expressing neurons after 7–10 days of culture. For the KATP channel
recordings, both the pipette and internal bath solution contained 140 mM
K+. Bath solutions with varying Mg2+-ATP concentrations were perfused
onto the cytoplasmic side of the membrane patches during recording.
All macroscopic currents were recorded at a membrane potential of 60 mV.
Slice Preparation and Whole-Cell Recordings
Brain slices were prepared from young adult mice (5–7 weeks old) as
described previously (Burdakov et al., 2005; Parton et al., 2007). GFP-positive
neurons were visualized using epifluorescence imaging and patched under
infrared differential interference contrast (IR-DIC) optics. Recordings were
made using a MultiClamp 700B amplifier using pClamp 9.0 softwareInc.
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Glucose Sensing by MCH Neurons(Axon Instruments). To further confirm if a recorded neuron was indeed aMCH
neuron, we examined the following electrophysiological properties of MCH
neurons: exhibition of spike rate adaptation and lack of a H-current mediated
voltage change as previously described (van den Pol et al., 2004).
Bath perfusions were used for changing glucose concentrations and for the
addition of 250 mM tolbutamide during recording. For aCSF solution containing
varying glucose level, the osmolarity was adjusted to the same level by adding
sucrose. Recording electrodes had resistances of 2.5–4 MU when filled with
the internal solution (128 mM K-gluconate, 10 mM HEPES, 1 mM EGTA,
10 mM KCL, 1 mM MgCl2, 0.3 mM CaCl2, 2 mM Na-ATP, 0.3 mM Na-GTP
[pH 7.35 with KOH]). Since the majority of MCH neurons are electrically silent,
under current clamp, depolarizing current pulses (20–30 pA, for 3 s, with 20 s
interval) were used to elicit action potentials for those silent neurons.SUPPLEMENTAL INFORMATION
Supplemental information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article at doi:10.1016/j.cmet.
2010.09.013.
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